Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
10/25/2001 | WO2001049288A9 Novel compounds and compositions as protease inhibitors |
10/25/2001 | WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
10/25/2001 | WO2001019798A3 Inhibitors of factor xa |
10/25/2001 | WO2000064896A9 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt |
10/25/2001 | WO2000061541A8 Pharmaceutical compounds |
10/25/2001 | WO2000056724A9 Oxazole and thiazole combinatorial libraries |
10/25/2001 | US20010034452 Epothilons C and D, preparation and compositions |
10/25/2001 | US20010034362 Pyrrolidine derivatives for vision and memory disorders |
10/25/2001 | US20010034359 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
10/25/2001 | US20010034352 Cardiovascular disorders |
10/25/2001 | US20010034351 A quinazoline compound |
10/25/2001 | US20010034348 Nitric oxide synthase inhibitor; nervous system disorders |
10/25/2001 | US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
10/25/2001 | DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease |
10/25/2001 | DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease |
10/25/2001 | CA2408396A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds |
10/25/2001 | CA2406271A1 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
10/25/2001 | CA2405919A1 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives |
10/25/2001 | CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase |
10/25/2001 | CA2402374A1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
10/25/2001 | CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
10/24/2001 | EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient |
10/24/2001 | EP1147772A1 Medicinal compositions for treatment of atrial fibrillation |
10/24/2001 | EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents |
10/24/2001 | EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors |
10/24/2001 | EP1147096A1 Herbicidal oxadiazolidines |
10/24/2001 | EP1147094A1 Non-peptide glp-1 agonists |
10/24/2001 | EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents |
10/24/2001 | EP1147092A1 Substituted imidazoles, their preparation and use |
10/24/2001 | EP1146875A1 Myt1 kinase inhibitors |
10/24/2001 | EP1146871A1 Antidepressant heterocyclic compounds |
10/24/2001 | EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
10/24/2001 | EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/24/2001 | EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
10/24/2001 | EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them |
10/24/2001 | CN1319092A Benzamide derivatives and their use as cytokine inhibitors |
10/24/2001 | CN1318372A Application of insulin sensitizing agent in treatment of nephrosis |
10/24/2001 | CN1073561C Alkyl sulphinyl and alkyl sulphonyl-1,2,4-thiadiazolyloxy acetamides and their use as herbicides |
10/23/2001 | US6307064 Process to prepare taxol |
10/23/2001 | US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
10/23/2001 | US6306877 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
10/23/2001 | US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals. |
10/23/2001 | US6306865 Pharmaceutically active benzoquinazoline compounds |
10/23/2001 | US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma |
10/23/2001 | US6306860 2,5-pyridinedicarboxylic acid derivatives |
10/23/2001 | CA2108064C Thiazolidine dione compounds, process for preparing same and pharmaceutical compositions containing same |
10/23/2001 | CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
10/18/2001 | WO2001077108A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them |
10/18/2001 | WO2001077101A1 Chemical compounds |
10/18/2001 | WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists |
10/18/2001 | WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
10/18/2001 | WO2001077091A2 Ns5b hcv polymerase inhibitors |
10/18/2001 | WO2001077090A2 Isothiazole derivatives and their use as microbicides |
10/18/2001 | WO2001077085A1 Quinazoline compounds |
10/18/2001 | WO2001077080A2 Pyrazole compounds having anti proliferative activity |
10/18/2001 | WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
10/18/2001 | WO2001077078A1 Novel pyridones and their use as modulators of serine hydrolase enzymes |
10/18/2001 | WO2000035903A3 Thiochromanoyl cyclohexenone derivatives |
10/18/2001 | US20010031869 Formation of bond between nitrogen atom of acridan ring and carbon atom of another aromatic or heteroaromatic ring compound; assays for peroxidase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs |
10/18/2001 | US20010031781 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors |
10/18/2001 | US20010031780 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv) |
10/18/2001 | US20010031759 Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
10/18/2001 | US20010031756 Inclusion complexes of aryl-heterocyclic salts |
10/18/2001 | EP1144401A3 Thiochromanoyl cyclohexenone derivatives |
10/18/2001 | CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
10/18/2001 | CA2405089A1 Benzoamide piperidine containing compounds and related compounds |
10/18/2001 | CA2405004A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them |
10/18/2001 | CA2403365A1 Quinazoline compounds |
10/18/2001 | CA2403012A1 Chemical compounds |
10/18/2001 | CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
10/17/2001 | EP1144408A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application |
10/17/2001 | EP1144407A1 Cyclic guanidine derivatives and their use as pesticides |
10/17/2001 | EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity |
10/17/2001 | EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors |
10/17/2001 | EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists |
10/17/2001 | EP1144401A2 Thiochromanoyl cyclohexenone derivatives |
10/17/2001 | EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
10/17/2001 | EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
10/17/2001 | EP1144390A2 Kinase inhibitors |
10/17/2001 | EP1144388A1 Acyl derivatives which treat vla-4 related disorders |
10/17/2001 | EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
10/17/2001 | EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones |
10/17/2001 | EP1143974A1 Pharmaceutical compositions for alleviating discomfort |
10/17/2001 | EP1143951A2 Antimalarial agents |
10/17/2001 | CN1318061A Thiazolylcinnamonitriles and pest controlling agents |
10/17/2001 | CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors |
10/17/2001 | CN1318055A Pyridine ketones useful as herbicides |
10/17/2001 | CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers |
10/17/2001 | CN1073098C Benzothiazolone derivatives |
10/17/2001 | CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines |
10/16/2001 | US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents |
10/16/2001 | US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative |
10/16/2001 | US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use |
10/16/2001 | US6303638 Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor |
10/16/2001 | US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors |
10/16/2001 | US6303627 For therapy of physiological and psychological disorders |
10/16/2001 | US6303615 2,3 disubstituded-4(3H)-quinazolinones |
10/16/2001 | US6303609 Used for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders |
10/16/2001 | US6303600 Substituted azabicyclic compounds |
10/16/2001 | US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis |